Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

• Autores principales: Caroline de Gouveia Buff Passone (Autor), Ruth Rocha Franco (Autor), Simone Sakura Ito (Autor), Evelinda Trindade (Autor), Michel Polak (Autor), Durval Damiani (Autor), Wanderley Marques Bernardo (Autor)
• Formato: Libro
• Publicado: BMJ Publishing Group, 2020-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients.Objectives To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS.Method We performed a systematic review and, where possible, meta-analysi...